कनाडा - अंग्रेज़ी - Health Canada

laboratoire riva inc. - norfloxacin - tablet - 400mg - norfloxacin 400mg - quinolones

कनाडा - अंग्रेज़ी - Health Canada

pharmascience inc - norfloxacin - tablet - 400mg - norfloxacin 400mg - quinolones

कनाडा - अंग्रेज़ी - Health Canada

pharmel inc - norfloxacin - tablet - 400mg - norfloxacin 400mg - quinolones

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - norfloxacin, quantity: 400 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin - the treatment of adults with complicated and uncomplicated urinary tract infections that are caused by susceptible strains of microorganisms. the treatment of adults with gastrointestional infections, in particular shigellosis and traveller's diarrhoea. note: specimens for culture and susceptibility testing should be obtained prior to and during treatment if clinical response warrants. suppression in adults of chronic, recurrent urinary tract infections.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - norfloxacin, quantity: 400 mg - tablet, film coated - excipient ingredients: macrogol 4000; hypromellose; colloidal anhydrous silica; magnesium stearate; propylene glycol; microcrystalline cellulose; lactose monohydrate; purified talc; titanium dioxide; croscarmellose sodium - treatment of adults with complicated and uncomplicated urinary tract infections that are caused by susceptible strains of microorganisms. treatment of adults with gastrointestinal infections, in particular shigellosis and traveller's diarrhoea. note: specimens for culture and susceptibility testing should be obtained prior to and during treatment if clinical response warrants. suppression, in adults, of chronic, recurrent urinary tract infection.

कनाडा - अंग्रेज़ी - Health Canada

cobalt pharmaceuticals company - norfloxacin - tablet - 400mg - norfloxacin 400mg - quinolones

कनाडा - अंग्रेज़ी - Health Canada

avanstra inc - norfloxacin - tablet - 400mg - norfloxacin 400mg - quinolones

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - norfloxacin -

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - norfloxacin 400mg - film coated tablet - 400 mg - active: norfloxacin 400mg excipient: calcium hydrogen phosphate colloidal silicon dioxide magnesium stearate opadry white oy-58900 purified talc sodium starch glycolate

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - norfloxacin, quantity: 400 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; sodium starch glycollate; colloidal anhydrous silica; magnesium stearate; purified talc; titanium dioxide; hypromellose; macrogol 400 - indications: the treatment of adults with complicated and uncomplicated urinary tract infections that are caused by susceptible strains of microorganisms. the treatment of adults with gastrointestional infections, in particular shigellosis and traveller's diarrhoea. note: specimens for culture and susceptibility testing should be obtained prior to and during treatment if clinical response warrants. suppression in adults of chronic, recurrent urinary tract infections.